Status:
UNKNOWN
A Comparison of IV Versus PO Acetaminophen Postoperatively for Opioid Consumption After Cesarean Section
Lead Sponsor:
Main Line Health
Collaborating Sponsors:
Sharpe-Strumia Research Foundation
Conditions:
Postoperative Pain
Cesarean Section
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
This randomized controlled study will compare narcotic consumption between two groups: patients that receive a perioperative dose of IV acetaminophen versus patients that receive a perioperative dose ...
Detailed Description
"Enhanced recovery" is an alternate management protocol described by a multi-modal, evidence based approach to peri-operative care, with the goal of accelerating recovery and return to normal activity...
Eligibility Criteria
Inclusion
- Women age 18 or older
- Scheduled to undergo a cesarean section
Exclusion
- Existing diagnosis of chronic pain
- Need to undergo a vertical skin incision
- Aspartate Aminotransferase (AST) \> 50, alanine aminotransferase (ALT) \> 70
- Platelets below 80,000 on admission
- Need to undergo general anesthesia
- Tubal ligation at time of Cesarean section
- Prior or known allergy to any of the medications being utilized in this study
Key Trial Info
Start Date :
August 22 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 23 2020
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04290208
Start Date
August 22 2019
End Date
June 23 2020
Last Update
February 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lankenau Medical Center
Wynnewood, Pennsylvania, United States, 19096